The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...
Entrada Therapeutics (NASDAQ:TRDA) gains recognition in Nasdaq Futures for its innovative approach to protein-based ...
Sana Biotechnology, Inc. stock will be surging today after the company showed it can safely administer its allogeneic cell therapy for diabetes to a patient with no immunosuppression. Engineered cells ...
A pioneer in Taiwan’s advanced manufacturing cell technologies, YJ Biotechnology has quickly established itself as one of the country’s leading names in the development of regenerative medicine.
Danmarks Tekniske Universitet The Novo Nordisk Foundation Center for Biosustainability Researchers at DTU Biosustain (The Novo Nordisk Foundation Center for Biosustainability at DTU) have developed a ...
Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they ...
EUDA Health Holdings Limited, a Singapore-based health technology company, has announced preliminary discussions with Guangdong Cell Biotech Co. Ltd., a leader in stem cell therapies and regenerative ...
As favor in the general market swings away from cell therapy, Immatics’ CEO is choosing to focus on what he can control: raising the bar for his biotech’s investigational treatment. “I at least ...
This article is authored by Amit Mookim, CEO, Immuneel Therapeutics Pvt. Ltd. and member, NATHEALTH.
Fortress Biotech, Inc. and its subsidiary Helocyte, Inc. have initiated a Phase 2 clinical trial to assess the efficacy of the Triplex vaccine, designed to prevent cytomegalovirus (CMV) reactivation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results